BETHANY FREE: Open Payments
NPI 1235736778 · HOUSTON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$384 in 18 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $384
Food & beverage: $384
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $232 |
| UCB, Inc. | 2 | $33 |
| Aurinia Pharma U.S., Inc. | 1 | $29 |
| Janssen Biotech, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $19 |
| ANI Pharmaceuticals, Inc. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: RINVOQ, SKYRIZI, Bimzelx, LUPKYNIS, TREMFYA, OFEV, ACTHAR, PURIFIED CORTROPHIN GEL.
Industry payments across MS — which companies pay providers there.
